Gen9, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-30. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Neil Cook | Director | Cambridge, MA |
| Drew Endy | Director | Cambridge, MA |
| James Hollenhorst | Director | Cambridge, MA |
| Joseph Jacobson | Director | San Jose, CA |
| Kevin Munnelly | Director | Cambridge, MA |
| Jacob Thaysen | Director | Cambridge, MA |
| Jeremy Wertheimer | Director | CAMBRIDGE, MA |
| Jennifer Camacho | Executive Officer | Cambridge, MA |
| Kevin Munnelly | Executive Officer | Cambridge, MA |
| David Stone | Executive Officer | New York, NY |
| Paul Manning | Director | Charlottesville, VA |
| George Church | Director | Austin, TX |
| George Church | Promoter | Austin, TX |
| Aaron Zucker | Executive Officer | Glendale, CA |
| Stanley Rose | Director | Mansfield, MA |
| Joseph Jacobson | Executive Officer | San Jose, CA |
| Joseph Jacobson | Promoter | San Jose, CA |
| Weili Dai | Director | Las Vegas, NV |
| Drew Endy | Promoter | Cambridge, MA |
| Stephen Jurvetson | Director | Menlo Park, CA |
| Jim Hollenhorst | Director | Santa Clara, CA |
| Bill Scalzulli | Director | Cambridge, MA |
| Scott Schoen | Director | Weston, MA |
| Lawrence Silverstein | Executive Officer | Boston, MA |
| Martin Goldberg | Executive Officer | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2013-05-07 | D | $21.0M | $21.0M |
| 2012-05-22 | D | $2.0M | $395K |
| 2011-09-09 | D | $9.6M | $1.6M |
| 2011-04-28 | D/A | $2.5M | $2.0M |
| 2011-02-10 | D | $2.0M | $1.7M |
| 2009-06-15 | D | $2.0M | $500K |